original ) (raw )HnRNP A1 controls a splicing regulatory circuit promoting mesenchymal-to-epithelial transition
D. Cabianca , Anna Di Matteo , Emanuele Buratti
Nucleic Acids Research, 2013
View PDFchevron_right
Resveratrol, by Modulating RNA Processing Factor Levels, Can Influence the Alternative Splicing of Pre-mRNAs
Brian Morris
PLoS ONE, 2011
View PDFchevron_right
The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
Martin Akerman
Nature Structural & Molecular Biology, 2012
View PDFchevron_right
Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells
MICHELE MAFFIA , Andrea Tinelli
Cancer Letters, 2011
View PDFchevron_right
Regulation of p53 and cell proliferation by resveratrol and its derivatives in breast cancer cells: An in silico and biochemical approach targeting integrin αvβ3
tze-chen hsieh
International Journal of Cancer, 2011
View PDFchevron_right
Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model
Wen-Wei Chang
Innate immunity, 2012
View PDFchevron_right
An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype
Michele Balsamo
PLoS genetics, 2011
View PDFchevron_right
Posttranscriptional regulation by RNA-binding proteins during epithelial-to-mesenchymal transition
Vanessa León Abella
Cellular and Molecular Life Sciences, 2013
View PDFchevron_right
Modulation of non-coding RNAs by resveratrol in ovarian cancer cells: In silico analysis and literature review of the anti-cancer pathways involved
Ciro Isidoro
Journal of Traditional and Complementary Medicine, 2020
View PDFchevron_right
Mammary epithelial-mesenchymal interaction regulates fibronectin alternative splicing via phosphatidylinositol 3-kinase
Matias Blaustein
Journal of Biological Chemistry, 2005
View PDFchevron_right
Transcription Factors OVOL1 and OVOL2 Induce the Mesenchymal to Epithelial Transition in Human Cancer
S Sud
PLoS ONE, 2013
View PDFchevron_right
Long non-coding RNAs regulated by TGFβ: lncRNA-HIT mediated TGFβ-induced epithelial to mesenchymal transition in mammary epithelia
Jennifer Permuth-wey
The Journal of biological chemistry, 2015
View PDFchevron_right
Resveratrol Modulates MED28 (Magicin/EG-1) Expression and Inhibits Epidermal Growth Factor (EGF)-Induced Migration in MDA-MB-231 Human Breast Cancer Cells
Hsu-Shan Huang
Journal of Agricultural and Food Chemistry, 2011
View PDFchevron_right
Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis
Frances Kittrell
Oncogene, 1999
View PDFchevron_right
Hypoxia-induced TGF-β–RBFOX2–ESRP1 axis regulates human MENA alternative splicing and promotes EMT in breast cancer
Jharna Mishra
NAR Cancer
View PDFchevron_right
Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEK1 and AP-1 signalling pathways
David Bickers
Experimental Dermatology, 2006
View PDFchevron_right
Downregulation of Lnc-Spry1 mediates TGF-β-induced epithelial-mesenchymal transition by transcriptional and posttranscriptional regulatory mechanisms
Gabriel Gonzalez Gutierrez
Cell death and differentiation, 2017
View PDFchevron_right
Resveratrol post-transcriptionally regulates pro-inflammatory gene expression via regulation of KSRP RNA binding activity
Huige Li
Nucleic Acids Research, 2014
View PDFchevron_right
miRNA-Mediated KHSRP Silencing Rewires Distinct Post-transcriptional Programs during TGF-β-Induced Epithelial-to-Mesenchymal Transition
Domenico Bordo
Cell Reports, 2016
View PDFchevron_right
The anti-inflammatory activity of the polyphenol resveratrol may be partially related to inhibition of tumour necrosis factor-α (TNF-α) pre-mRNA splicing
monica varela
Molecular Immunology, 2010
View PDFchevron_right
Resveratrol and Tumor Microenvironment: Mechanistic Basis and Therapeutic Targets
wamidh talib
Molecules, 2020
View PDFchevron_right
Splicing factor ratio as an index of epithelial-mesenchymal transition and tumor aggressiveness in breast cancer
Michel Rigaud
Oncotarget, 2016
View PDFchevron_right
The Estrogen Receptor α Signaling Pathway Controls Alternative Splicing in the Absence of Ligands in Breast Cancer Cells
Michele De Bortoli
Cancers
View PDFchevron_right
An alternative splicing switch in FLNB promotes the mesenchymal cell state in human breast cancer
Huong Ly
eLife, 2018
View PDFchevron_right
Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells
Dominique Delmas
Biochemical Pharmacology, 2010
View PDFchevron_right
hnRNP E1 at the crossroads of translational regulation of epithelial-mesenchymal transition
Simon Grelet , Journal of Cancer Metastasis and Treatment
Journal of Cancer Metastasis and Treatment , 2019
View PDFchevron_right
Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways
Bhupendra Singh
Carcinogenesis, 2014
View PDFchevron_right
Polyphenolic Nutrients in Cancer Chemoprevention and Metastasis: Role of the Epithelial-to-Mesenchymal (EMT) Pathway
Temesgen Samuel
Nutrients, 2017
View PDFchevron_right
β1-Integrin plays a major role in resveratrol-mediated anti-invasion effects in the CRC microenvironment
Prof. Dr. Mehdi Shakibaei
2022
View PDFchevron_right
Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules
Prof. Dr. Mehdi Shakibaei
Nutrients, 2017
View PDFchevron_right
DSCAM-AS1-Driven Proliferation of Breast Cancer Cells Involves Regulation of Alternative Exon Splicing and 3′-End Usage
Elena Doria
Cancers, 2020
View PDFchevron_right